Edition:
United States

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

8.11CAD
14 Dec 2018
Change (% chg)

$-0.01 (-0.12%)
Prev Close
$8.12
Open
$8.11
Day's High
$8.23
Day's Low
$7.97
Volume
38,583
Avg. Vol
36,936
52-wk High
$8.65
52-wk Low
$5.68

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.07 0.10 0.03 --
Quarter Ending Mar-19 1 0.10 0.10 0.10 --
Year Ending Dec-18 2 0.48 0.50 0.47 0.22
Year Ending Dec-19 2 0.21 0.30 0.12 0.12
Earnings (per share)
Quarter Ending Dec-18 2 -0.16 -0.11 -0.20 --
Quarter Ending Mar-19 1 -0.22 -0.22 -0.22 --
Year Ending Dec-18 2 -0.74 -0.70 -0.78 -0.62
Year Ending Dec-19 2 -0.68 -0.45 -0.90 -0.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta 2.13 1.08 0.91
Price to Sales (TTM) 1,306.17 49.58 6.22
Price to Book (MRQ) 3.08 10.17 5.20
Price to Tangible Book (MRQ) 3.36 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions -- 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 498.18 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 86.28 47.89 6.50
Sales - 5 Yr. Growth Rate -28.98 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 71.27 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago -161.99 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -53.80 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 53.07 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 99.29 56.37 54.44
Gross Margin - 5 Yr. Avg. 98.72 60.62 52.36
EBITD Margin (TTM) -7,859.62 -- --
EBITD - 5 Yr. Avg -847.60 -110.03 13.16
Operating Margin (TTM) -8,206.41 -185.03 6.07
Operating Margin - 5 Yr. Avg. -984.31 -126.47 8.47
Pre-Tax Margin (TTM) -16,648.93 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -996.77 -132.63 8.71
Net Profit Margin (TTM) -16,648.93 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -946.52 -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 26,384 7,648,872 873,051,409
Net Income/Employee (TTM) -4,392,666 653,324 103,483,755
Receivable Turnover (TTM) 2.52 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -58.90 6.47 11.45
Return on Assets - 5 Yr. Avg. -49.46 5.54 12.50
Return on Investment (TTM) -60.83 9.01 14.96
Return on Investment - 5 Yr. Avg. -57.68 6.87 16.23
Return on Equity (TTM) -70.80 10.15 16.52
Return on Equity - 5 Yr. Avg. -85.46 8.40 17.37
  1 Year 3 Year 5 Year
Sales % -26.38 -43.69 -28.98
EPS (TTM) % -14.09 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aurinia Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.10 -3.68 91 98
13 Week 0.73 -3.76 99 94
26 Week -12.39 -12.73 75 98
52 Week 22.88 14.03 99 68
YTD 192.23 184.04 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.64%
# of Holders: 85
Total Shares Held: 24,440,681
3 Mo. Net Change: 157,907
# New Positions: 11
# Closed Positions: 14
# Increased Positions: 28
# Reduced Positions: 34
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.